Frontiers in Neurology · 2021 · 16 citations · 32 references
MedicineNeurologyNeuroscienceDementiaMemoryNeuropsychiatryBrain ImagingCognitive AssessmentCognitive Function AssessmentCognitive ImpairmentCognitive SymptomsPositron Emission TomographyCerebral Metabolic RateCognitive Ability ProfilesCognitive Decline DetectionCognitive Impairment DetectionDomain-specific Cognitive ProfilesMetabolic Brain ImagingMultiple System Atrophy ImagingNeuroimaging Of Cognitive Impairment
Objective: We aimed to characterize the cognitive profiles in multiple system atrophy (MSA) and explore the cerebral metabolism related to the cognitive decline in MSA using 18 F-fluorodeoxyglucose ( 18 F-FDG) Positron Emission Tomography (PET). Methods: In this study, 105 MSA patients were included for cognitive assessment and 84 of them were enrolled for 18 F-FDG PET analysis. The comprehensive neuropsychological tests covered five main domains including execution, attention, memory, language, and visuospatial function. The cognitive statuses were classified to MSA with normal cognition (MSA-NC) and MSA with cognitive impairment (MSA-CI), including dementia (MSA-D), and mild cognitive impairment (MSA-MCI). With 18 F-FDG PET imaging, the cerebral metabolism differences among different cognitive statuses were analyzed using statistical parametric mapping and post-hoc analysis. Results: Among 84 MSA patients, 52 patients were found with MSA-CI, including 36 patients as MSA-MCI and 16 patients as MSA-D. In detail, the cognitive impairments were observed in all the five domains, primarily in attention, executive function and memory. In 18 F-FDG PET imaging, MSA-D and MSA-MCI patients exhibited hypometabolism in left middle and superior frontal lobe compared with MSA-NC ( p < 0.001). The normalized regional cerebral metabolic rate of glucose (rCMRglc) in left middle frontal lobe showed relative accuracy in discriminating MSA-CI and MSA-NC [areas under the curve (AUC) = 0.750; 95%CI = 0.6391–0.8609]. Conclusions: Cognitive impairments were not rare in MSA, and the hypometabolism in frontal lobe may contribute to such impairments.
32
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman, Gregor K. Wenning, Phillip A. Low et al. · Neurology · 2008 · 3.2K citations · Full text
FDG PET in the differential diagnosis of parkinsonian disorders
Thomas Eckert, Anna Barnes, Vijay Dhawan et al. · NeuroImage · 2005 · 421 citations
Medicine, Neurology, Neuroscience +16